RAPT (RAPT)
RAPT Therapeutics, Inc.
NASDAQ:RAPTHealthcare · Biotechnology
Mkt Cap-
Float5.96M
O/S-
Inst Own-
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$0
Net Income-$129.87M
Total Assets$240.32M
Free Cash Flow-$83.42M
Debt & Equity
Debt 2%
Equity 98%
Total Debt$4.49M
Total Equity$189.9M
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
2-year cumulative
1:8
Nasdaq bars a compliance period at 1:250
- 1:8Reverse splitJun 17, 20258 shares → 1
Balance Sheet Details
Assets$240.32M
Liabilities$50.42M
Accounts Receivable$0
Accounts Payable$1.27M
Inventory$0
PP&E (Net)$4.7M
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
| Revenue | $0 | $0 | $1.53M | $3.81M | $5.04M | $0 | $0 | $0 |
| YoY Growth | - | - | -60.0% | -24.4% | - | - | - | - |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 | $1.33M | $1.24M | $1.38M |
| Gross Profit | $0 | $0 | $1.53M | $3.81M | $5.04M | -$1.33M | -$1.24M | -$1.38M |
| Gross Margin | - | - | 100.0% | 100.0% | 100.0% | - | - | - |
| Research and Development | $107.22M | $101M | $67.08M | $56.98M | $45.48M | $34.91M | $31.77M | $25.62M |
| Selling, General, and Administrative | $28.88M | $26.06M | $20.24M | $16.04M | $12.77M | $8.72M | $5.18M | $3.71M |
| Other | $0 | $0 | $0 | $0 | $0 | $1.29M | $800K | $216K |
| Total Operating Expenses | $136.1M | $127.06M | $87.32M | $73.02M | $58.26M | $43.63M | $36.95M | $29.33M |
| Operating Income (EBIT) | -$136.1M | -$127.06M | -$85.8M | -$69.21M | -$53.21M | -$43.63M | -$36.95M | -$29.33M |
| Operating Margin | - | - | -5618.5% | -1815.1% | -1055.4% | - | - | - |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Interest Income | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Income (Expense) | $6.24M | $10.26M | $1.96M | $5K | $1.31M | $1.29M | $800K | $216K |
| Income Before Tax (EBT) | -$129.87M | -$116.8M | -$83.84M | -$69.2M | -$51.9M | -$42.34M | -$36.15M | -$29.11M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $990K | $660K | $0 | $0 |
| Net Income | -$129.87M | -$116.8M | -$83.84M | -$69.2M | -$52.89M | -$43M | -$36.15M | -$29.11M |
| Net Income Margin | - | - | -5490.4% | -1814.9% | -1049.0% | - | - | - |
| Supplementary Data | ||||||||
| EPS | -3.19 | -3.05 | -2.58 | -2.53 | -2.19 | -1.97 | -1.70 | -1.37 |
| Diluted EPS | -3.19 | -3.05 | -2.58 | -2.53 | -2.19 | -1.97 | -1.70 | -1.37 |
| Weighted Average OS | 40.76M | 38.34M | 32.54M | 27.39M | 24.13M | 21.83M | 21.28M | 21.28M |
| EBITDA | -$128.66M | -$115.58M | -$82.79M | -$68.21M | -$52.09M | -$42.3M | -$35.71M | -$27.95M |
| EBITDA Margin | - | - | -5421.8% | -1788.8% | -1033.1% | - | - | - |
Balance Sheet
| Period | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
| Assets | ||||||||
| Current Assets | ||||||||
| Cash and Cash Equivalents | $169.74M | $47.48M | $38.95M | $24.03M | $24.92M | $77.38M | $63.8M | $47.52M |
| Short-Term Investments | $61.32M | $111.38M | $210.12M | $165.63M | $86.59M | $0 | $0 | $0 |
| Cash and Short-Term Investments | $231.06M | $158.86M | $249.07M | $189.65M | $111.51M | $77.38M | $63.8M | $47.52M |
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $4.18M | $2.92M | $3.63M | $3.32M | $4.09M | $0 | $0 | $0 |
| Total Current Assets | $235.24M | $161.78M | $252.69M | $192.97M | $115.6M | $80.51M | $65.06M | $48.24M |
| Long-Term Assets | ||||||||
| Property, Plant & Equipment Net | $4.7M | $7.68M | $9.48M | $2.74M | $2.98M | $3.71M | $4.16M | $1.91M |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $598K | $605K |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $389K | $3.87M | $4.04M | $2.92M | $389K | $389K | -$209K | -$369K |
| Total Long-Term Assets | $5.09M | $11.55M | $13.52M | $5.66M | $3.37M | $4.1M | $4.55M | $2.15M |
| Other Assets | $1K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $240.32M | $173.33M | $266.21M | $198.64M | $118.97M | $84.6M | $69.61M | $50.39M |
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts Payable | $1.27M | $5.18M | $3.37M | $2M | $2.38M | $1.14M | $1.77M | $1.11M |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $1.02M | $4.1M | $4M | $0 | $0 |
| Other Current Liabilities | $6.78M | $7.91M | $4.65M | $2.93M | $2.3M | $2.25M | $586K | $650K |
| Total Current Liabilities | $48.35M | $21.84M | $14.22M | $9.6M | $11.74M | $9.26M | $4.64M | $3.25M |
| Long-Term Liabilities | ||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $108.64M |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $511K | $863K | $0 | $969K | $905K |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | -$162.08M | -$108.64M |
| Other Long-Term Liabilities | $0 | $0 | $0 | $2.15M | $2.19M | $2.23M | $969K | $905K |
| Total Long-Term Liabilities | $2.07M | $4.46M | $6.82M | $2.66M | $3.05M | $2.23M | $969K | $109.55M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $50.42M | $26.29M | $21.04M | $12.26M | $14.79M | $11.48M | $5.61M | $112.8M |
| Stockholders' Equity | ||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $161.11M | $108.64M |
| Common Stock | $13K | $3K | $3K | $3K | $2K | $2K | $2K | $1K |
| Retained Earnings | -$614.55M | -$484.68M | -$367.88M | -$284.05M | -$214.84M | -$161.95M | -$118.95M | -$82.81M |
| Comprehensive Income & Other | $50K | $103K | -$26K | -$206K | -$177K | $20K | -$4K | -$3.77M |
| Other Stockholders' Equity | $804.44M | $631.71M | $613.05M | $470.42M | $319.02M | $235.07M | $182.95M | $20.4M |
| Total Equity | $189.9M | $147.03M | $245.17M | $186.38M | $104.18M | $73.12M | $64M | -$62.41M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $240.32M | $173.33M | $266.21M | $198.64M | $118.97M | $84.6M | $69.61M | $50.39M |
| Supplementary Data | ||||||||
| Total Debt | $4.49M | $6.91M | $8.99M | $0 | $0 | $0 | $161.11M | $108.64M |
| Net Debt | -$165.24M | -$40.57M | -$29.96M | -$24.03M | -$24.92M | -$77.38M | $97.31M | $61.13M |
Cash Flow Statement
| Period | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
| Operating Activities | ||||||||
| Net Income | -$129.87M | -$116.8M | -$83.84M | -$69.2M | -$52.89M | -$43M | -$36.15M | -$29.11M |
| Depreciation & Amortization | $1.2M | $1.22M | $1.05M | $996K | $1.12M | $1.33M | $1.24M | $1.38M |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $17K | $15K |
| Stock-Based Compensation | $19.93M | $17.09M | $11.26M | $9.95M | $8.69M | $2.05M | $1.17M | $716K |
| Changes in Working Capital: | ||||||||
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | -$8.46M | $7.33M | $3.71M | $933K | $2.39M | $736K | $1.48M | -$80K |
| Other Working Capital | $34.37M | -$1.84M | -$5.04M | -$5.23M | -$46K | $3.4M | -$691K | -$34K |
| Total Working Capital Change | $25.91M | $5.5M | -$1.33M | -$4.3M | $2.34M | $4.13M | $784K | -$114K |
| Other Non-Cash Items | -$477K | -$4.06M | $2.09M | $1.53M | $248K | $9K | -$14K | -$9K |
| Net Cash from Operating | -$83.3M | -$97.05M | -$70.77M | -$61.03M | -$40.49M | -$35.47M | -$32.95M | -$27.12M |
| Investing Activities | ||||||||
| Capital Expenditures | -$122K | -$1.13M | -$845K | -$755K | -$398K | -$888K | -$3.5M | -$1.12M |
| Acquisitions | $0 | $0 | $44.65M | $80.59M | $87.04M | $0 | $0 | $0 |
| Purchases of Investments | -$82.22M | -$161.5M | -$190.86M | -$164.98M | -$139.33M | $0 | $0 | $0 |
| Sales of Investments | $135.04M | $266.75M | $146.21M | $84.39M | $52.3M | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | -$44.65M | -$80.59M | -$87.04M | $45K | $0 | $0 |
| Net Cash from Investing | $52.7M | $104.13M | -$45.49M | -$81.35M | -$87.44M | -$843K | -$3.5M | -$1.12M |
| Financing Activities | ||||||||
| Debt Repaid | - | - | - | - | - | - | - | - |
| Common Stock Issuance | $152.01M | $1.45M | $129.79M | $139.46M | $73.61M | $35.52M | $266K | $246K |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $845K | $0 | $1.39M | $2.02M | $1.85M | $0 | $52.73M | $30.1M |
| Net Cash from Financing | $152.85M | $1.45M | $131.18M | $141.48M | $75.46M | $49.9M | $52.73M | $30.1M |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $122.26M | $8.53M | $14.92M | -$891K | -$52.47M | $13.59M | $16.28M | $1.85M |
| Supplementary Data | ||||||||
| Operating Cash Flow | -$83.3M | -$97.05M | -$70.77M | -$61.03M | -$40.49M | -$35.47M | -$32.95M | -$27.12M |
| Capital Expenditure | -$122K | -$1.13M | -$845K | -$755K | -$398K | -$888K | -$3.5M | -$1.12M |
| Free Cash Flow | -$83.42M | -$98.17M | -$71.62M | -$61.78M | -$40.89M | -$36.36M | -$36.45M | -$28.25M |
| Cash at Beginning | $47.48M | $38.95M | $24.03M | $24.92M | $77.38M | $63.8M | $47.52M | $45.66M |
| Cash at End | $169.74M | $47.48M | $38.95M | $24.03M | $24.92M | $77.38M | $63.8M | $47.52M |